Related Experiment Videos
Nitric oxide, mitochondria and neurological disease
S J Heales1, J P Bolaños, V C Stewart
1Department of Clinical Biochemistry, National Hospital, Queen Square, London WC1N 3BG, UK. sheales@ion.ucl.ac.uk
Biochimica Et Biophysica Acta
|March 17, 1999
Summary
Mitochondrial damage from nitric oxide (NO) and peroxynitrite (ONOO-) contributes to neurological diseases like Parkinson's and Alzheimer's. Neurons are particularly vulnerable, leading to cell death and energy deficiency.
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Biochemistry
Background:
- Mitochondrial electron transport chain (ETC) damage is implicated in neurological disorders.
- Excessive nitric oxide (NO) and peroxynitrite (ONOO-) generation are increasingly linked to these conditions.
- NO/ONOO- can inhibit mitochondrial respiration, causing cellular energy deficits.
Purpose of the Study:
- To review the role of NO/ONOO- mediated mitochondrial damage in neurological disease pathogenesis.
- To explore the differential vulnerability of brain cell types to NO/ONOO-.
- To discuss potential therapeutic strategies targeting this pathway.
Main Methods:
- Literature review and synthesis of existing evidence.
- Analysis of cellular mechanisms of NO/ONOO- toxicity in the brain.
- Examination of cell-type specific responses (neurons vs. astrocytes).
Main Results:
- NO/ONOO- inhibit mitochondrial ETC components, leading to energy depletion.
- Neuronal cells are more susceptible than astrocytes due to lower glutathione (GSH) and impaired glycolytic compensation.
- Astrocyte-derived NO/ONOO- can damage neighboring neurons, as seen in multiple sclerosis.
Conclusions:
- NO/ONOO- induced mitochondrial dysfunction is a key mechanism in various neurological disorders.
- Therapeutic strategies should aim to mitigate NO/ONOO- toxicity or protect mitochondria.
- Understanding cell-specific vulnerabilities is crucial for targeted treatments.